Cancer-associated fibroblasts promote epithelial-mesenchymal transition and EGFR-TKI resistance of non-small cell lung cancers via HGF/IGF-1/ANXA2 signaling-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cancer-associated fibroblasts promote epithelial-mesenchymal transition and EGFR-TKI resistance of non-small cell lung cancers via HGF/IGF-1/ANXA2 signaling

Published:2018-03 Issue:3 Volume:1864 Page:793-803
ISSN:0925-4439
Container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Author:

Yi Yanmei,Zeng Shanshan,Wang Zhaotong,Wu Minhua,Ma Yuanhuan,Ye Xiaoxia,Zhang Biao,Liu Hao

Funder

National Natural Science Foundation of China

Innovation Project of Guangdong Education Department

Scientific Research Project of Guangzhou Municipal Colleges and Universities

Publisher

Elsevier BV

Subject

Molecular Biology,Molecular Medicine

Reference61 articles.

1. Cancer statistics, 2016;Siegel;CA Cancer J. Clin.,2016

2. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib;Lynch;N. Engl. J. Med.,2004

3. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy;Paez;Science,2004

4. EGFR-mutated oncogene-addicted non-small cell lung cancer: current trends and future prospects;Soria;Cancer Treat. Rev.,2012

5. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR;Maemondo;N. Engl. J. Med.,2010

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer-associated fibroblast cell surface markers as potential biomarkers or therapeutic targets in lung cancer;Cancer Drug Resistance;2024-09-10

2. Mechanisms of resistance to tyrosine kinase inhibitor‐targeted therapy and overcoming strategies;MedComm;2024-08-24

3. Inhibition of insulin-like growth factors increases production of CXCL9/10 by macrophages and fibroblasts and facilitates CD8+ cytotoxic T cell recruitment to pancreatic tumours;Frontiers in Immunology;2024-08-05

4. Cancer-associated fibroblasts mediate resistance to anti-EGFR therapies in cancer;Pharmacological Research;2024-08

5. Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma therapy: Challenges and opportunities;Cancer Letters;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3